- Supported exchanges /
- F /
- 8GN.F
CESSATECH A/S DK -20 (8GN F) stock market data APIs
Cessatech A/S engages in identifying and developing drugs for the treatment of medical unmet need in children in Denmark. The company's lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for magnetic resonance imaging scanning; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S was incorporated in 2020 and is based in Copenhagen, Denmark.
CESSATECH A/S DK -20 Financial Data Overview
| 1.73 | |
| 1.68 | |
| - | |
| 1.8 | |
| 1.68 | |
| 0.497-2.9 | |
| 35 533 K | |
| 17 425 K | |
| 0 | |
| 0.286 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
CESSATECH A/S DK -20 Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA 0
- Earnings Per Share -0.26
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get CESSATECH A/S DK -20 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get CESSATECH A/S DK -20 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
